The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 255.60
Bid: 240.00
Ask: 275.00
Change: 0.00 (0.00%)
Spread: 35.00 (14.583%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 255.60
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

25 Oct 2017 17:46

RNS Number : 6399U
Man Group plc
25 October 2017
 

 

Transaction in our own shares

 

Man Group plc (the "Company") announces that on 25th October 2017 it purchased for cancellation 267,547 of its ordinary shares with a weighted average price of 189.4687 pence per ordinary share pursuant to its US$100 million share repurchase programme, details of which were announced on 13th October 2017. The highest price paid per share was 190.40 pence and the lowest price paid per share was 188.60 pence. Details of the relevant repurchase transactions are set out below:

 

Description of shares: Man Group plc - ordinary shares 3 3/7 cents

 

Number of shares repurchased: 267,547

 

Date of transaction: 25 October 2017

 

Time of transaction: 08:05 - 16:35

 

Price: 189.4687p

 

Broker: Credit Suisse Securities (Europe) Limited

 

Since the commencement of the share repurchase programme, the Company has repurchased 1,471,847 ordinary shares in aggregate at a weighted average price of 189.4211 pence per share.

 

Following the cancellation of these shares, the remaining number of ordinary shares in issue will be 1,652,292,244.

 

The Company does not hold any shares in treasury.

 

All transactions under this programme will be published on the Company's website (www.man.com) on a weekly basis.

 

Enquiries

 

Fiona Smart

Head of Investor Relations

+44 20 7144 2030

fiona.smart@man.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSPGGGCUUPMGQA
Date   Source Headline
17th Aug 20216:03 pmRNSTransaction in Own Shares
17th Aug 202110:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
16th Aug 20215:59 pmRNSTransaction in Own Shares
16th Aug 202112:05 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Aug 20215:20 pmRNSTransaction in Own Shares
13th Aug 202111:05 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
12th Aug 20215:57 pmRNSTransaction in Own Shares
12th Aug 202111:23 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20215:45 pmRNSTransaction in Own Shares
11th Aug 202110:36 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20217:00 amRNSTransaction in Own Shares
10th Aug 202111:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Aug 20217:00 amRNSShare buyback programme of up to $100 million
9th Aug 20219:41 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Aug 20219:39 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
6th Aug 20219:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:30 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:26 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
4th Aug 20212:12 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
4th Aug 20212:09 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Aug 202112:28 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
3rd Aug 202112:25 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:42 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Aug 20211:38 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:34 pmGNWMan Group PLC : Form 8.3 - John Laing Group plc
2nd Aug 20217:00 amRNSTotal Voting Rights
30th Jul 20211:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
30th Jul 20211:25 pmGNWMan Group PLC : Form 8.3 - St.Modwen Properties plc
30th Jul 20211:20 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
29th Jul 20214:20 pmRNSDirector/PDMR Shareholding
29th Jul 20211:56 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
29th Jul 20211:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
29th Jul 20211:51 pmGNWMan Group PLC : Form 8.3 - Morrison (WM) Supermarket plc
28th Jul 20216:01 pmRNSTransaction in Own Shares
28th Jul 20211:40 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
28th Jul 20211:32 pmGNWMan Group PLC : Form 8.3 - Morrison (WM) Supermarket plc
28th Jul 20217:00 amRNSHalf-year Report
27th Jul 20215:45 pmRNSTransaction in Own Shares
27th Jul 202110:46 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
27th Jul 202110:40 amGNWMan Group PLC : Form 8.3 - Morrison (WM) Supermarket plc
26th Jul 20215:50 pmRNSTransaction in Own Shares
26th Jul 20212:21 pmGNWMan Group PLC : Form 8.3 - Morrison (WM) Supermarket plc
26th Jul 20212:17 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
23rd Jul 20215:57 pmRNSTransaction in Own Shares
23rd Jul 202111:55 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
22nd Jul 20215:41 pmRNSTransaction in Own Shares
22nd Jul 202111:08 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
21st Jul 20215:51 pmRNSTransaction in Own Shares
21st Jul 202110:36 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
21st Jul 202110:34 amGNWMan Group PLC : Form 8.3 - Morrison (WM) Supermarket plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.